Developmental Pathway Funding Scheme (DPFS)
This funding opportunity from the Medical Research Council (MRC) supports the development and early-phase testing of novel therapeutics, diagnostics, medical devices, and health interventions. The scheme is intended to progress projects along the developmental pipeline from early-stage research through to Phase 2a clinical studies.
Eligibility Criteria:
-
Only applicants who were invited after a successful Stage One DPFS application or panel-approved resubmission may apply
-
Must be based at an eligible UK research institution
-
International co-leads from high-income countries may apply, with cost limits
-
Project leads must actively direct and contribute to the proposed work
Funding Details:
-
Total fund available: 30,000,000 British Pounds.
-
No specific funding cap per project (must be justified and appropriate)
-
MRC funds up to 80% of the full economic cost
-
Covers salaries, equipment, consumables, travel, data sharing, and international co-lead costs (up to 30% for high-income country participants)
-
Funding for all developmental stages up to Phase 2a trials
-
Typical projects include 2 to 4 SMART milestones with clear go/no-go criteria
Deadline:
2 July 2025 at 4:00 PM UK time
(Next rounds close every March, July, and November)
Where to Go for Further Information:
Visit: https://www.ukri.org/opportunity/developmental-pathway-funding-scheme-invited-stage-two
Contact: [email protected]
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023